Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vogmet (Voglibose/Metformin) in Type 2 Diabetes
NCT01370707Phase 3Completed
- Sponsor
- HK inno.N Corporation
- Start
- Apr 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of voglibose in type 2 diabetes mellitus (T2DM), sponsored by HK inno.N Corporation. Started Apr 2011; status: completed.
02
Drugs
voglibose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01370707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370707.